Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1136/gutjnl-2012-303824

Type

Journal article

Journal

Gut

Publication Date

06/2013

Volume

62

Pages

803 - 807

Keywords

Biosimilar Pharmaceuticals, Humans, Inflammatory Bowel Diseases, Therapeutic Equivalency, Treatment Outcome